Why it mattersEurope’s four new unicorns show how widely investors are placing their bets, from electric motorcycles to financial AI, while a single $5 billion drug-discovery round shows where the biggest checks are going.
Four European-founded companies crossed the billion-dollar valuation mark in the week of 16 November 2026, spanning electric motorcycles, robotics, financial AI and cybersecurity. The largest deal came from drug discovery, where Isomorphic Labs raised $5 billion without disclosing its valuation.
Spain’s Stark Future, founded by Anton Wass and Paul Soucy, raised more than €150 million at a €1.2 billion pre-money valuation to scale its electric off-road motorcycles. France’s Genesis AI, led by co-founders Zhou Xian and Théophile Gervet, raised $500 million at a $3.5 billion valuation to develop general-purpose robots.
British brothers Chaz and Arnie Englander took Model ML to a $1.5 billion valuation with a $250 million Series B. The company builds AI agents for financial and professional services. Germany-founded IGEL Technology, started by Heiko Gloge, surpassed $1 billion following a strategic investment from Vitruvian Partners. Sofia-founded Payhawk, already a unicorn since 2022, raised $280 million at a $2 billion valuation.
In life sciences, Sir Demis Hassabis’s Isomorphic Labs dominated the week by deal size. Switzerland’s Windward Bio secured $251.2 million through its IPO and a concurrent Sanofi investment. London-based Boltz raised $110 million for AI-driven molecular design, while Denmark’s Commit Biologics closed a $60 million seed round for its immunotherapy platform.
The clearest founder equity figure came from a public filing. Windward Bio founder Luca Santarelli’s disclosed shares were worth approximately $78.4 million at the IPO price. Stark Future founder Anton Wass’s stake would be worth €180 million on paper if he owned 15% before the round. His actual ownership remains undisclosed, leaving the estimate dependent on that assumption.